Showing results (381-390 of 1,039) with videos related to

Sort By:
Pageof 104
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|April 21, 2010
Comparative genome mapping reveals evidence of gene conversion between Sox9 paralogs of rainbow trout (Oncorhynchus mykiss)Mahmoud A Alfaqih, Craig A Steele, Robert T Morris, et al.
European Urology|October 24, 2003
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancerW See, P Iversen, M Wirth, et al.
Molecular Biology International|November 18, 2011
Glycolysis in the african trypanosome: targeting enzymes and their subcellular compartments for therapeutic developmentApril F Coley, Heidi C Dodson, Meredith T Morris, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2000
Impaired endothelium-dependent vasodilatation in uraemiaS T Morris, J J McMurray, R S Rodger, et al.
Nucleic Acids Research|October 19, 2013
High-resolution characterization of CPD hotspot formation in human fibroblastsAnamaria G Zavala, Robert T Morris, John J Wyrick, et al.
Cancers|June 10, 2022
Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung CancerDingxie Liu, Jonathan Benzaquen, Luc G T Morris, et al.
The Journal of Biological Chemistry|April 5, 2008
Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzymeJeremy W Chambers, Margaret T Kearns, Meredith T Morris, et al.
The Journal of Surgical Research|August 12, 2022
Development of a Risk Score to Predict Post-Discharge Rehabilitation Care After Liver MetastasectomyMaria Urdaneta Perez, Katherine T Morris, Kenneth Stewart, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?A V Kaisary, P Iversen, C J Tyrrell, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groupsDavid Hsiehchen, Magdalena Espinoza, Cristina Valero, et al.
Pageof 104